Association Between Hypothyroidism and IPF Risk May Be Immune Mediated
-
Pharma Companies Race to Develop New Therapies for Older Patients With SMAIntrathecal onasemnogene abeparvovec aims to address the genetic root cause of SMA by replacing the SMN1 gene in a single dose. -
MGFA Honors British Neurologist With First Lifetime Award for Groundbreaking MG ResearchAfter starting in clinical medicine at her parents' urging, Dr. Vincent switched to her field of interest: basic research. -
Orthopedic Care for Achondroplasia Rapidly Evolving as New Strategies EmergeOrthopedic management plays a central role in the care of patients with achondroplasia. -
Emerging Solutions Could Make TK2d Easier to Recognize and TreatTK2d has long existed in a therapeutic void, with patients having few, if any, disease-modifying treatment options. -
SMA Continues to Challenge Patients Who Couldn’t Be Treated Early in InfancyLyza Weisman spoke at the recent MDA Clinical & Scientific Conference of no longer being able to do the 'little things' that make a life.
-
Navigating the Friedreich Ataxia Experience and Learning There’s No One WayI experience living with a rare, chronic disease differently than everyone else, and I think that’s fine. There’s no correct FA experience.July 21, 2025 -
My Grandson’s Sudden Loss of Mobility and What FollowedWilliam lives with Duchenne muscular dystrophy (DMD), so stumbling 5 or 10 times a day is normal for him.July 21, 2025
-
Exploring the Link Between AATD and SAA AmyloidosisPatients with alpha-1 antitrypsin deficiency (AATD) should know signs and symptoms of related conditions so they can monitor their health and advocate for better care.July 18, 2025 -
Living With CIDP and Knowing When Your Nerves Are FriedI had been diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP) and had lost all feeling in my feet and ankles.July 18, 2025
-
Challenges in Treatment Decisions and the Value of MRD in CLLDeciding when and how to treat chronic lymphocytic leukemia (CLL) remains challenging, with MRD-guided strategies offering new insights. -
The Role of ANCA Serotype in the AAV Diagnostic ProcessStudies show that ANCA seropositivity can be immensely useful in helping physicians identify a likely final diagnosis. -
How Healthcare Professionals Regard Genetic Testing in HAEHealthcare professionals generally agree that genetic testing can be useful in the HAE diagnostic process, but many urge caution in interpreting results. -
Emerging Priorities in Diagnosing and Managing Gaucher DiseaseCurrent evidence suggests there are 8 key areas of emerging importance in diagnosing and managing Gaucher disease. -
Biomarkers Play Key Role in Diagnosing NMOSD and Tracking Disability ProgressionBiomarkers are increasingly recognized for their use in diagnosing and tracking disability progression in NMOSD.
- Achondroplasia
- Acute Lymphoblastic Leukemia
- Alagille Syndrome
- Alpha-1 Antitrypsin Deficiency
- ANCA-Associated Vasculitis
- Cholangiocarcinoma
- Chronic Inflammatory Demyelinating Polyneuropathy
- Chronic Lymphocytic Leukemia
- Cold Agglutinin Disease
- Cystic Fibrosis
- Diffuse Large B-Cell Lymphoma
- Dravet Syndrome
- Duchenne Muscular Dystrophy
- Fabry Disease
- Fetal and Neonatal Alloimmune Thrombocytopenia
- Friedreich Ataxia
- Gastrointestinal Stromal Tumor
- Gaucher Disease
- Generalized Pustular Psoriasis
- Hemolytic Disease of the Fetus and Newborn
- Hemophilia
- Hepatocellular Carcinoma
- Hereditary Angioedema
- Huntington Disease
- Idiopathic Pulmonary Fibrosis
- IgG4-Related Disease
- Immune Thrombocytopenia
- Lennox-Gastaut Syndrome
- Limb Girdle Muscular Dystrophy
- Long Chain Fatty Acid Oxidation Disorder
- Lysosomal Acid Lipase Deficiency
- Medullary Thyroid Carcinoma
- Multiple Sclerosis
- Myasthenia Gravis
- Myelodysplastic Syndromes
- Myelofibrosis
- Neuromyelitis Optica Spectrum Disorder
- Paroxysmal Nocturnal Hemoglobinuria
- Pompe Disease
- Prader-Willi Syndrome
- Primary Biliary Cholangitis
- Primary Central Nervous System Lymphoma
- Pulmonary Arterial Hypertension
- Sickle Cell Disease
- Spinal Muscular Atrophy
- Systemic Mastocytosis
- Systemic Sclerosis
- Thymidine Kinase 2 Deficiency
- Transthyretin Amyloid Polyneuropathy
- Transthyretin-Mediated Amyloid Cardiomyopathy
- Wilson Disease
